© 2024 MergersCorp M&A International.
© 2024 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
The company was founded in the district Punjab India, 1982 with a purpose of manufacturing Active Pharmaceutical Ingredients.
The company is an active pharmaceutical ingredient (API) manufacturing company that manufactures the raw materials for several leading companies of the pharma industry, who use these products for making medicines.
They supply products to companies such as Pfizer, Abbott, Cipla, Glenmark, Macleods, Aristo, etc.
The company is offerings range from Antibiotics, vitamins, anti-coagulants to ophthalmic products. Business is also audited by several organizations such as ISO, ZED and also GMP by regulatory bodies in India and overseas.
Research
Business is working on a patented technology for a recombinant protein which works on a novel targeted therapy and also assures no side effects. Currently, operations focus on high-end novel molecules.
Studies
Company is presently conducting experimental studies on stem cell rejuvenation therapies which also promise a future of medication without any side effects.
Biotechnology
The company is engaged in undertaking significant biotechnology research activities in the area of targeted human therapeutic proteins. Its current research work focuses on creating a novel drug, which while curing asthma and allergy patients can also work on mastocytosis and basophilic leukemia.
Team
The team is composed by 100 enlightened individuals, Chemists, Pharmacists, Biotechnologists, Quality controllers, R & D experts, Warehousing personnel.
Market: 65% India / 35% Rest of the World / Europe
Products: 25 OEM Products / Pharma Active Ingredients Raw Material
Most Sold: Antibiotics
Standards: ISO9001, EU Standards (No FDA)
Growth Rate: 20%+ / Year
Size: 100+ Employees
Management: Chemical Engineer Background
Financial: $25M Revenue / $3M EBITDA
Customers:
© 2024 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
This website is operated by MergersUS Inc a US Corporation with registered office at
Error: Contact form not found.
Error: Contact form not found.
Error: Contact form not found.
Error: Contact form not found.
Description
The company was founded in the district Punjab India, 1982 with a purpose of manufacturing Active Pharmaceutical Ingredients.
The company is an active pharmaceutical ingredient (API) manufacturing company that manufactures the raw materials for several leading companies of the pharma industry, who use these products for making medicines.
They supply products to companies such as Pfizer, Abbott, Cipla, Glenmark, Macleods, Aristo, etc.
The company is offerings range from Antibiotics, vitamins, anti-coagulants to ophthalmic products. Business is also audited by several organizations such as ISO, ZED and also GMP by regulatory bodies in India and overseas.
Research
Business is working on a patented technology for a recombinant protein which works on a novel targeted therapy and also assures no side effects. Currently, operations focus on high-end novel molecules.
Studies
Company is presently conducting experimental studies on stem cell rejuvenation therapies which also promise a future of medication without any side effects.
Biotechnology
The company is engaged in undertaking significant biotechnology research activities in the area of targeted human therapeutic proteins. Its current research work focuses on creating a novel drug, which while curing asthma and allergy patients can also work on mastocytosis and basophilic leukemia.
Team
The team is composed by 100 enlightened individuals, Chemists, Pharmacists, Biotechnologists, Quality controllers, R & D experts, Warehousing personnel.
Market: 65% India / 35% Rest of the World / Europe
Products: 25 OEM Products / Pharma Active Ingredients Raw Material
Most Sold: Antibiotics
Standards: ISO9001, EU Standards (No FDA)
Growth Rate: 20%+ / Year
Size: 100+ Employees
Management: Chemical Engineer Background
Financial: $25M Revenue / $3M EBITDA
Customers:
Basic Details
Target Price:
$40,000,000
Gross Revenue
$25,000,000
EBITDA
$3,000,000
Business ID:
L#20210013
Country
India
City:
Vadodara
Detail
Similar Businesses
Published on December 13, 2022 at 2:46 pm. Updated on December 2, 2023 at 10:35 pm
15-Year-Old Large Confectionery Production Business
$2,600,000
Manufacturing
20-Year Old FIFA Accredited Colored SBR Granule Manufacturing Business
€4,500,000
Manufacturing
30-Year-Old Historic company producing make-up stations and illuminated mirrors
TBD
Manufacturing
Leading Salt Manufacturing Business
€11,000,000
Manufacturing
Manufacturer of Oil & Gas Equipments
$6,500,000
Manufacturing
Italian Pasta Manufacturer Business “Made in Italy”
TBD
Manufacturing
PREVIOUS PROPERTY
Premium Coal Mining Business
NEXT PROPERTY
Russian Intermodal Logistics Terminal